Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02939170 · ClinicalTrials.gov registry record · NA
Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks
A NA study, sponsored by Alcon, a Novartis Company.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT02939170 is a NA study that has completed, run by Alcon, a Novartis Company. The registered enrollment target is 87 participants.
The verdict
NCT02939170, a NA study, has completed, sponsored by Alcon, a Novartis Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the impact of back surface molded marks (MM) applied to delefilcon A contact lenses as measured by the incidence of ocular discomfort device-related adverse events with DAILIES TOTAL1® Multifocal contact lenses with molded marks (DT1 MF MM) and current DAILIES TOTAL1® Multifocal contact lenses (DT1 MF).
Interventions
- DEVICE Delefilcon A Multifocal Contact Lenses with Molded Mark
- DEVICE Delefilcon A Multifocal Contact Lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2016-11-14 |
| Est. Completion | 2016-12-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02939170
The ClinicalTrials.gov registry entry for NCT02939170 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon, a Novartis Company, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Delefilcon A Multifocal Contact Lenses with Molded Mark is the first listed.
NCT02939170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02939170 about?
NCT02939170 is a clinical study titled "Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks". The purpose of this study is to evaluate the impact of back surface molded marks (MM) applied to delefilcon A contact lenses as measured by the incidence of ocular discomfort device-related adverse events with DAILIES TOTAL1® Multifocal contact lenses with molded marks (DT1 MF MM) and current DAILIE...
What is the current status of trial NCT02939170?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2016-11-14. Estimated completion is 2016-12-02.
What interventions are being tested in trial NCT02939170?
The interventions under investigation include: Delefilcon A Multifocal Contact Lenses with Molded Mark (DEVICE), Delefilcon A Multifocal Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT02939170?
This trial is sponsored by Alcon, a Novartis Company, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.